Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Immutep Announces Positive Update from Phase I Study of IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases
-
ALL4 Mining Expands Affiliate Program to Fuel Platform Growth and Community Engagement
-
RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
-
Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the Amer
-
Guardforce AI Strengthens Decade-Long Client Relationships by Securing Long-term Contract with Government Savings Bank
-
Xcel Brands Announces Strategic Partnership with Global Fashion Icon Coco Rocha
-
Fengate appoints Darcy Wilson as transportation lead
-
Abacus Global Management Announces New Corporate Commercial Campaign at Recent Investor Day in NYC
-
Oatly to Report Second Quarter 2025 Financial Results on July 23, 2025
-
Skyline Corporate Communications Group, LLC Announces Sponsorship and Attendance at the ORY APAC-US Conference, July 8th – 9th in Singapore, Co-Hosted by Nasdaq
-
Changes in the Kalmar leadership team: Kalmar appoints Hanna Reijonen as Senior Vice President, Human Resources
-
ASML reports transactions under its current share buyback program
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer
-
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
-
Form 8.3 - Marlowe plc - Octopus Investments
-
Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder
-
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
-
Form 8.3 - AXA INVESTMENT MANAGERS: Empiric Student Property plc
-
Woodbridge Announces Sale of Custom Chemical Solutions, LLC to AAVIN Private Equity
-
Market Intelligence on Autopilot: St Mary Capital Delivers Real-Time Feed
-
Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
-
Tiny nation targets climate investors to become citizens and help it change the world
-
Palvella Therapeutics Completes Enrollment in Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations, Exceeding Enrollment Target by Over 25%
-
CorMedix inc. Announces Customer Implementation
-
NFI’s New Flyer secures order from Brampton Transit for additional 55 buses
-
New Wave Announces Non-Brokered Private Placement of Units
-
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
-
NETCLASS TECHNOLOGY INC and Nanyang Institute of Social Sciences Join Forces to Explore New Paths in Smart Education
-
Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type
-
Vote Habit Burger’s Double Char #1, Get the #1 for $1
-
AGF Investments Announces June 2025 Cash Distributions for Certain AGF ETFs and ETF Series
-
Lottery.com Regains Nasdaq Compliance as Stock Trading Activity Soars
-
Alterity Therapeutics to Provide Corporate Update in Fireside Chat
-
Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
-
Flow Capital Announces US$1.5M Follow-On Investment in Tattle
-
Attorney Launches Squeaky Clean Solution to Messy RIA Compliance
-
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
-
Churchill Reports High-Grade Silver Results up to 395 g/t Silver at the Black Raven Property, Central Newfoundland
-
USA Rare Earth Bolsters Global Sales Effort with Appointment of Ron Fogarty as Vice President of Sales
-
New DoseSpot Analysis of 100,000 GLP-1 Prescriptions Finds That Patients Overpaid by $10.2M Collectively
-
Changes in Nokia Corporation's own shares
-
Larimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich’s Ataxia Program
-
Aya Gold & Silver Closes Credit Facility with the EBRD to Support Boumadine Development
-
Sono-Tek Receives $1.12 Million Order from Global Medical Diagnostics Company for High-Volume Coating Platform
-
ArriVent Announces Positive Interim Firmonertinib Monotherapy Data From Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer and Plans to Advance into a Global Pivotal Study
-
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza
-
Skye Bioscience Shares Nimacimab “Anatomy of Progress” Video Series and Highlights Preclinical CB1 Antibody Data Presented at the American Diabetes Association’s 85th Scientific Sessions
-
AltruBio Presents New Preclinical Data at FOCIS 2025 Demonstrating ALTB-268’s Efficacy in T Cell-Mediated Inflammatory Models
-
Denovo Biopharma LLC Enters into an Exclusive Out-License Agreement with Chuang Yi Global Asset Management Co., Ltd. for Biomarker-Guided DB104 (liafensine) in Patients with Treatment-Resistant Depres
